4. Fowler JR, Simon LV. Chorioamnionitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK532251/
8. Ericson JE, Laughon MM. Chorioamnionitis: implications for the neonate. Clin Perinatol. 2015 Mar;42(1):155-65, ix.
9. Fried M, Barak O, Brezinov Y, Ayalon MY, Flidel O, Levy R, et al. 650:The impact of the new ACOG 2017 classification on the incidence of suspected intraamniotic infection. American Journal of Obstetrics and Gynecology. 2019;220(1):431 – 432.
10. Johnson CT, Farzin A, Burd I. Current management and long-term outcomes following chorioamnionitis. Obstet Gynecol Clin North Am. 2014 Dec;41(4):649-69.
11. Novianesari PH, Bernolian N, Maulani H, Ramadanti A, Theodorus. Comparison between leukocyte esterase activity and histopathological examination in indentifying chorioamnionitis. Case Reports in Perinatal Medicine.2017;7(1).
12. Malloy MH. Chorioamnionitis: epidemiology of newborn management and outcome United States 2008. J Perinatol. 2014 Aug;34(8):611-5.
13. Stimac M, Juretić E, Vukelić V, Matasić NP, Kos M, Babić D. Effect of chorioamnionitis on mortality, early onset neonatal sepsis and bronchopulmonary dysplasia in preterm neonates with birth weight of < 1,500 grams. Coll Antropol. 2014 Mar;38(1):167-71.
14. Lau J, Magee F, Qiu Z, Houbé J, Von Dadelszen P, Lee SK. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):708-13.